VA
VRTX icon

VestGen Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

VestGen Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Sell
2,199
-73
-3% -$32.4K 0.03% 439
2026
Q1 		$1.02M Buy
2,272
+245
+12% +$114K 0.03% 457
2025
Q4 		$919K Sell
2,027
-519
-20% -$224K 0.04% 373
2025
Q3 		$997K Sell
2,546
-515
-17% -$215K 0.03% 369
2025
Q2 		$1.36M Sell
3,061
-202
-6% -$93.1K 0.05% 276
2025
Q1 		$1.58M Buy
+3,263
New +$1.52M 0.07% 237

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

VestGen Advisors's VRTX Position: Q2 2026 in Review

VestGen Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 3.2% in Q2 2026, selling an estimated $32.4K and leaving 2,199 shares worth $1.09M. The position accounts for 0.03% of the portfolio, ranked #439.

VestGen Advisors first reported a position in VRTX in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.58M in Q1 2025. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • VestGen Advisors held 2,199 shares of Vertex Pharmaceuticals worth $1.09M as of Q2 2026.
  • VestGen Advisors sold 73 Vertex Pharmaceuticals shares in Q2 2026, an estimated $32.4K.
  • Vertex Pharmaceuticals made up 0.03% of VestGen Advisors's portfolio in Q2 2026, its #439 holding.
  • VestGen Advisors first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • VestGen Advisors's Vertex Pharmaceuticals position peaked at $1.58M in Q1 2025.
  • 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on VestGen Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.